Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05099926 · ClinicalTrials.gov registry record · NA
The Reducing Exercise Sensitivity With Exposure Training (RESET) Study
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05099926: Clinical Trial NA study, sponsored by Columbia University.
NCT05099926 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05099926, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study investigates the feasibility of conducting a home-based reducing exercise sensitivity with exposure training (RESET) intervention among acute coronary syndrome (ACS) survivors. RESET is an at-home, 2 visit intervention that involves psychoeducation, a brief, low-to-moderate intensity walking session (i.e., interoceptive exposure), and interoceptive counseling, and is designed to reduce exercise sensitivity (i.e., fear of exercise sensations) and improve participation in exercise-based secondary-prevention guidelines (cardiac rehabilitation and physical activity). The primary purpose of this pilot study is to test the feasibility, acceptability, and appropriateness of recruiting and administering the RESET intervention in ACS patients.
Primary Outcome
As a measure of adherence, the investigator will assess the percentage of participants that complete a majority of the home-based RESET intervention visits.
Interventions
- BEHAVIORAL Reducing Exercise Sensitivity with Exposure Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-10-13 |
| Est. Completion | 2023-02-03 |
| Phase | NA |
Why NCT05099926 stopped before completion
NCT05099926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Reducing Exercise Sensitivity with Exposure Training is the first listed.
NCT05099926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05099926 about?
NCT05099926 is a clinical study titled "The Reducing Exercise Sensitivity With Exposure Training (RESET) Study". This study investigates the feasibility of conducting a home-based reducing exercise sensitivity with exposure training (RESET) intervention among acute coronary syndrome (ACS) survivors. RESET is an at-home, 2 visit intervention that involves psychoeducation, a brief, low-to-moderate intensity walk...
What is the current status of trial NCT05099926?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2021-10-13. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05099926?
The interventions under investigation include: Reducing Exercise Sensitivity with Exposure Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05099926?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05099926's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI